Showing results (291-300 of 309) with videos related to

Sort By:
Pageof 31
Atherosclerosis|March 21, 2001
Polymorphisms in the thrombopoietin gene are associated with risk of myocardial infarction at a young ageK E Webb, J F Martin, A Hamsten, et al.
Journal of Internal Medicine|October 22, 2005
Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarctionA Samnegård, A Silveira, P Lundman, et al.
FEBS Letters|December 12, 1997
Increased expression of alpha-enolase in c-jun transformed rat fibroblasts without increased activation of plasminogenA C Bergman, C Linder, K Sakaguchi, et al.
Circulation|April 13, 1999
Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosisB Zhang, S Ye, S M Herrmann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 28, 2007
Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH studyP E Morange, N Saut, M C Alessi, et al.
Journal of Internal Medicine|February 22, 2011
Plasma CD93 concentration is a potential novel biomarker for coronary artery diseaseA Mälarstig, A Silveira, D Wågsäter, et al.
Metabolism: Clinical and Experimental|July 16, 2004
Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH studyJ S Yudkin, I Juhan-Vague, E Hawe, et al.
Atherosclerosis|March 22, 2005
Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH studyP E Morange, N Saut, M C Alessi, et al.
European Heart Journal|February 25, 2005
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidityK Malmberg, L Rydén, H Wedel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2002
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of EuropeI Juhan-Vague, P E Morange, H Aubert, et al.
Pageof 31